Ann: Fondaparinux Quarterly Profit Share , page-28

Prior to Fonda hitting the market sales were $338 mill in US 12mths to June 2011. Over the last year Reddys average market share was 28%,
or $40.87 mill. That means that since Fonda and apotex have hit the market, the annual sales have dropped from $338m to $146m. Now that to me (and according to Alchemias own chart in price reduction with only 2 generics) is a drastic drop in annual sales. Seems all of a sudden the demand for Fonda has dropped significantly since increased competition. I smell a rat.

It reminds me of golf... When I am keeping track of the figures, I always come out on top.